Harrow (HROW) Work In Process (2014 - 2026)

Harrow's (HROW) quarterly Work In Process came in at $589000.0 in Q1 2026, up 290.07% year-on-year from $151000.0 in Q1 2025, and down 43.15% quarter-over-quarter from $1.0 million in Q4 2025.

Harrow (HROW) Work In Process (2014 - 2026) Analysis & Trends

Harrow's Work In Process history runs 10 years deep, the most recent figure standing at $589000.0 for Q1 2026.

  • On a quarterly basis, Work In Process rose 290.07% year-over-year to $589000.0 in Q1 2026; TTM through Mar 2026 was $589000.0, a 290.07% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 20.75% from the prior year.
  • Work In Process eased to $589000.0 in Q1 2026 per HROW's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.0 million in Q4 2025 and bottomed at $7000.0 in Q2 2022.
  • The 5-year median for Work In Process is $137000.0 (2024), against an average of $300000.0.
  • Across the five-year window, Work In Process slumped 58.82% in 2022 and jumped 1488.89% in 2024, its largest moves.
  • Year by year, Work In Process stood at $38000.0 in 2022, then surged by 42.11% to $54000.0 in 2023, then soared by 1488.89% to $858000.0 in 2024, then advanced by 20.75% to $1.0 million in 2025, then tumbled by 43.15% to $589000.0 in 2026.
  • Per Business Quant, the three latest HROW Work In Process figures stand at $589000.0 (Q1 2026), $1.0 million (Q4 2025), and $842000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 589,000.00
Dec 31, 2025 1.04 Mn
Sep 30, 2025 842,000.00
Jun 30, 2025 793,000.00
Mar 31, 2025 151,000.00
Dec 31, 2024 858,000.00
Sep 30, 2024 176,000.00
Jun 30, 2024 137,000.00
Mar 31, 2024 140,000.00
Dec 31, 2023 54,000.00
Sep 30, 2023 113,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 36,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 26,000.00
Jun 30, 2022 7,000.00
Mar 31, 2022 44,000.00
Sep 30, 2021 51,000.00
Jun 30, 2021 17,000.00
Mar 31, 2021 3,000.00